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Abstract
Purpose: Vascular intervention studies generally consider patency and limb salvage as primary outcomes. However,
quality of life is increasingly considered an important patient-oriented outcome measurement of vascular interventions.
Existing literature was analyzed to determine the effect of different treatments on quality of life for patients suffering
from either claudication or critical limb ischemia.
Basic methods: A review of the literature was undertaken in the Medline library. A search was performed on quality of
life in peripheral arterial disease. Results were stratified according to treatment groups.
Principal findings: Twenty-one articles described quality of life in approximately 4600 patients suffering from peripheral
arterial disease. Invasive treatment generally results in better quality of life scores (at a maximum of 2 years of follow-up),
compared with non-invasive treatment. In patients with critical limb ischemia, successful revascularization improves
quality of life scores. Only one study reported long-term results.
Conclusions: Increase in quality of life scores can be found for any intervention performed for peripheral arterial
disease. However, there is scarce information on long-term quality of life after vascular intervention.
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Introduction
Peripheral arterial disease (PAD) is commonly caused
by atherosclerosis of peripheral arteries. The prevalence
of PAD is 3–10% in the current population and ranges
up to 15–20% in the elderly population.1–4 PAD is
categorized by the Rutherford classiﬁcation.5
Rutherford classiﬁcations 1 to 3 are used for patients
suﬀering from intermittent claudication. These patients
can be treated either with exercise therapy or
revascularization.1
In patients with critical limb ischemia, Rutherford
classiﬁcations 4 to 6, the need for intervention is inev-
itable, which can either be performed by a percutaneous
transluminal angioplasty (PTA), peripheral bypass sur-
gery or, when this is technically not possible, primary
amputation or palliation.1 Typically, reported out-
comes of vascular interventions include walking dis-
tance, patency rates, limb salvage rates and operative
mortality.5 However, these outcomes may reﬂect a phy-
sician-oriented view on results.
Quality of life (QoL) is increasingly considered an
important outcome of vascular interventions.2,6 It is an
individual assessment of physical, psychological and
social well-being that is based on the deﬁnition of
health by the World Health Organization.7 QoL
incorporates a patient’s individual perception of his/
her disease and functioning.8 Patients suﬀering from
PAD frequently cope with a deprived health status
and QoL due to the general eﬀects of the disease and
co-morbid conditions.8 In this perspective, QoL is a
patient-oriented way of evaluating results and may
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provide a better-balanced estimate of the impact of a
certain intervention for patients.
There are reviews available on diﬀerent topics of
QoL in vascular surgery. However, these are mostly
outdated and they assess only a small spectrum of
QoL in vascular surgery.
We decided to conduct a systematic literature review
to analyze the eﬀect of exercise therapy, endovascular
procedures and surgical interventions on the QoL of
patients suﬀering from lower limb ischemia.
Methods
This review is based on a search in the Medline library,
which was accessed by the PubMed search engine on
31 December 2011. The search was based on both med-
ical subject headings [MeSH] and normal search terms
and was performed by the ﬁrst author, aided by the
institution’s librarian.
Terms used were ‘‘Peripheral Vascular Diseases’’
[MeSH] and ‘‘quality of life’’ [MeSH] (215 results)
and ‘‘Peripheral arterial disease’’ [MeSH] and
‘‘Quality of Life’’ (36 results). All titles and abstracts
were read, and all articles which were not referring to
QoL in peripheral vascular surgery were excluded
(n¼ 232). Nineteen manuscripts were selected for thor-
ough revision. Three manuscripts were excluded, and
from all references read ﬁve manuscripts were included
in the review. QoL was deﬁned as outcome, either
primary or secondary. All relevant articles were fully
read, and possible references were included and read
as well.
Inclusion criteria
All papers that reported QoL scores after the following
interventions in PAD were included: exercise therapy,
PTA procedures and surgical revascularization. QoL
had to be assessed with a questionnaire. Only articles
published in English were included. Papers had to be
published before 1 January 2012.
QoL assessment
There are many diﬀerent questionnaires used to assess
patients’ QoL. There are generic QoL questionnaires
like the WHOQOL and the EQ-5D questionnaires, dis-
ease speciﬁc questionnaires like the VascuQoL ques-
tionnaire or health status questionnaires like the
SF-36 and RAND-36 questionnaires.
Results
A total of 21 studies were included which analyzed
approximately 4600 patients. These studies were
distributed by type of intervention as follows: QoL
after exercise therapy (N¼ 5); QoL after endovascular
procedures (N¼ 11); and QoL after open surgery
(N¼ 13).
Many studies have analyzed and reported QoL results
after all diﬀerent types of vascular treatment, in either
patients suﬀering from intermittent claudication9–16 or
patients with critical limb ischemia,17–21 or studies with
both groups of patients.22–32 There are studies compar-
ing endovascular treatment with bypass sur-
gery,9,12,18,19,24,28 studies comparing endovascular
therapy with exercise therapy,9,14 studies comparing
autologous bypass surgery with Polytetraﬂuoroethylene
(PTFE) bypass surgery22 and studies analyzing QoL
after a single intervention.13,15–17,20,21,23,25,27,29–32
QoL after exercise therapy
Five articles assessed QoL in patients after exercise ther-
apy.9,13–16 All articles assessed QoL in patients suﬀering
from intermittent claudication. Exercise therapy, both
supervised and unsupervised, resulted in increment in
QoL at a maximum of 24 months of follow-up.
However, results of supervised exercise therapy were
better compared to the unsupervised exercise therapy.13
Patients receiving invasive treatment (both
endovascular and surgical reconstruction) showed
more increment in QoL than patients who only received
exercise therapy.14 For detailed information on studies
analyzing QoL after exercise therapy, see Table 1.
QoL after endovascular procedures
Eleven articles assessed QoL in patients after endovas-
cular procedures.9,12,14,18,19,23–25,28,31,32 For patients
suﬀering from intermittent claudication, an increase
in QoL could be expected up to 2 years of follow-up.14
Patients with critical limb ischemia also showed
increased QoL up to 36 months of follow-up after
endovascular treatment.18 The diﬀerence in QoL
between patients suﬀering from critical limb ischemia
and patients suﬀering from intermittent claudication
remains unclear, as diﬀerent papers report in contrast
to each other.24,25 A study analyzing QoL in critical
limb ischemia patients after endovascular procedures,
bypass surgery and secondary amputations stated that
achieving limb salvage was related to better QoL.19 One
case-control study reported that both intermittent clau-
dication patients and critical limb ischemia patients
cope with a deprived QoL score compared to matched
healthy control subjects.28
Endovascular treatment can increase QoL, even for
chronically occluded superﬁcial femoral arteries.23 For
detailed information on studies analyzing QoL after
PTA, see Table 2.
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QoL after open surgical procedures
Thirteen articles assessed QoL in patients after surgi-
cal revascularization procedures.9,12,14,17–20,22,24,27–30
Surgical revascularization improved QoL in patients
suﬀering from both intermittent claudication and crit-
ical limb ischemia, at least for two to three years after
surgery. The increment in QoL achieved by a surgical
revascularization intervention was signiﬁcantly better
compared to walking exercise.9,14
Little is known about the long-term eﬀect of endo-
vascular or surgical reconstructive interventions on
patients’ QoL. Only one prospective study analyzed
results after more than 2 years of follow-up, after
both endovascular and surgical reconstructive proced-
ures.18 They showed an increment in QoL for both pro-
cedures after 3 years of follow-up. A case-control
study28 showed that QoL scores of patients after
both endovascular and surgical reconstructions (mean
3.5 years for surgery, 2.7 years for PTA) were lower
compared to healthy subjects. One study analyzed
long-term follow-up results (mean follow-up of
11 years) after reconstructive surgery,29 and they
reported decrement in QoL scores for patients treated
with surgical reconstructions. Especially patients who
experienced an adverse event during the follow-up
period scored lower on QoL. For detailed information
on studies analyzing QoL after surgical revasculariza-
tion, see Table 3.
Discussion
Our systematic review involving approximately 4600
patients subjected to supervised walking therapy, endo-
vascular or open revascularization revealed that for
every performed intervention in PAD, some degree of
increase in QoL scores was observed. However, this
improvement varies signiﬁcantly depending on the
type of population (intermittent claudication vs. critical
limb ischemia), the intervention performed and the type
of QoL scoring method used. QoL scores also varied
signiﬁcantly with the duration of follow-up, which sug-
gests that QoL in patients with PAD is very dynamic
and multifactorial.
For patients suﬀering from intermittent claudication,
walking advice itself can increase QoL scores as demon-
strated by Nicolai et al.13 However, supervised walking
exercise results in better QoL scores. Nordanstig et al.14
and Currie et al.9 reported increased QoL scores after
walking exercise. They also stated that QoL could be
further improved after invasive treatment with either
endovascular intervention or surgical treatment.
In patients suﬀering from critical limb ischemia,
endovascular treatment can result in improved QoL
scores. A few studies analyzed the diﬀerence in QoL
between endovascular and surgical intervention.T
a
b
le
2
.
C
o
n
ti
n
u
e
d
A
rt
ic
le
N
st
ar
t/
e
n
d
Q
u
e
st
io
n
n
ai
re
s
Fe
m
al
e
(%
)
A
ge
a
D
e
gr
e
e
o
f
is
ch
e
m
ia
Fo
llo
w
-u
p
m
o
n
th
s
O
u
tc
o
m
e
M
e
an
ch
an
ge
P
va
lu
e
B
o
sc
h
e
t
al
.3
2
e
1
3
6
/1
3
6
E
Q
-5
D
2
7
6
0
M
o
st
ly
cl
au
d
ic
an
t
2
4
P
hy
si
ca
l
fu
n
ct
io
n
4
0
N
R
G
r
2
R
an
d
-3
6
P
hy
si
ca
l
ro
le
1
0
0
N
R
P
ai
n
4
5
N
R
E
Q
-5
D
in
d
e
x
0
.2
0
N
R
N
S:
n
o
t
si
gn
ifi
ca
n
t;
N
R
:
n
o
t
re
p
o
rt
e
d
.
O
n
ly
ar
ti
cl
e
s
re
p
o
rt
in
g
tr
e
at
m
e
n
t
sp
e
ci
fic
b
e
fo
re
an
d
af
te
r
d
at
a
ar
e
lis
te
d
.
a
M
e
an
o
r
m
e
d
ia
n
.
b
E
ff
e
ct
si
ze
(d
iff
e
re
n
ce
in
m
e
an
va
lu
e
s
b
e
tw
e
e
n
b
as
e
lin
e
an
d
2
ye
ar
s
p
e
r
SD
at
b
as
e
lin
e
).
c
D
at
a
ar
e
fo
r
in
va
si
ve
tr
e
at
m
e
n
t
gr
o
u
p
(P
T
A
þ
su
rg
e
ry
).
d
Tw
e
lv
e
-m
o
n
th
fo
llo
w
-u
p
w
as
se
le
ct
e
d
b
e
ca
u
se
o
f
ve
ry
lit
tl
e
fo
llo
w
-u
p
at
3
6
m
o
n
th
s
(o
ri
gi
n
al
st
u
d
y
e
n
d
p
o
in
t)
.
e
St
u
d
y
co
n
si
st
e
d
o
f
tw
o
gr
o
u
p
s:
fir
st
u
n
d
e
rw
e
n
t
P
T
A
þ
St
e
n
t,
se
co
n
d
o
n
e
u
n
d
e
rw
e
n
t
P
T
A
o
n
ly
.
92 Vascular 24(1)
T
a
b
le
3
.
C
h
an
ge
fr
o
m
b
as
e
lin
e
in
q
u
al
it
y
o
f
lif
e
af
te
r
su
rg
ic
al
re
co
n
st
ru
ct
iv
e
tr
e
at
m
e
n
t.
A
rt
ic
le
N
st
ar
t/
e
n
d
Q
u
e
st
io
n
n
ai
re
s
Fe
m
al
e
(%
)
A
ge
a
D
e
gr
e
e
o
f
is
ch
e
m
ia
Fo
llo
w
-u
p
m
o
n
th
s
O
u
tc
o
m
e
M
e
an
ch
an
ge
P
va
lu
e
C
u
ri
e
e
t
al
.9
3
4
/3
4
SF
-3
6
3
2
6
7
C
la
u
d
ic
an
t
3
P
hy
si
ca
l
fu
n
ct
io
n
1
8
(9
5
%
C
I:
1
5
–
2
6
)
<
0
.0
0
2
P
hy
si
ca
l
ro
le
1
6
(9
5
%
C
I:
1
–
3
0
)
<
0
.0
5
P
ai
n
1
7
(9
5
%
C
I
6
–
2
7
)
<
0
.0
1
V
it
al
it
y
9
(9
5
%
C
I:
2
–
1
7
)
<
0
.0
5
E
n
ge
lh
ar
d
t
e
t
al
.1
7
8
9
/4
7
SF
-3
6
2
8
7
1
C
ri
ti
ca
l
2
4
P
hy
si
ca
l
fu
n
ct
io
n
2
0
<
0
.0
0
1
P
hy
si
ca
l
ro
le
1
1
N
S
P
ai
n
2
1
<
0
.0
0
1
V
it
al
it
y
1
0
N
S
Jo
h
n
so
n
e
t
al
.1
9
4
4
/3
5
D
o
m
ai
n
Q
4
2
7
1
C
ri
ti
ca
l
1
2
P
ai
n
3
<
0
.0
1
B
ar
th
e
l
A
D
L
sc
o
re
0
.0
5
<
0
.0
1
M
o
b
ili
ty
1
<
0
.0
0
1
v
H
at
tu
m
e
t
al
.2
9
4
8
2
/5
3
E
Q
-5
D
2
9
7
3
C
la
u
d
ic
an
t
7
2
%
M
e
an
1
3
2
E
Q
-5
D
in
d
e
x
0
.1
6
(9
5
%
C
I:
1
.9
–
0
.2
7
)
0
.0
0
4
R
an
d
-3
6
P
hy
si
ca
l
fu
n
ct
io
n
2
0
(9
5
%
C
I:
3
0
–
9
)
0
.0
0
1
C
ri
ti
ca
l
2
8
%
P
hy
si
ca
l
ro
le
1
5
N
S
P
ai
n
1
N
S
V
it
al
it
y
7
N
S
O
zt
u
rk
e
t
al
.2
2
1
0
1
/9
3
W
H
O
Q
O
L
2
6
6
9
C
la
u
d
ic
an
t
3
4
%
3
P
hy
si
ca
l
d
o
m
ai
n
þ1
0
.0
<
0
.0
0
0
5
C
ri
ti
ca
l
6
6
%
G
e
n
e
ra
l
Q
o
L
0
.1
4
0
.0
7
8
W
o
h
lg
e
m
u
th
e
t
al
.3
0
7
4
/7
4
SF
-3
6
N
R
5
7
.7
C
la
u
d
ic
an
t
3
0
1
8
P
hy
si
ca
l
fu
n
ct
io
n
1
7
<
0
.0
5
C
ri
ti
ca
l
7
0
%
P
hy
si
ca
l
ro
le
3
8
<
0
.0
5
P
ai
n
5
7
<
0
.0
5
V
it
al
it
y
2
2
N
S
N
gu
ye
n
e
t
al
.2
0
1
4
0
4
/7
3
2
V
as
cu
Q
o
l
3
6
6
9
C
ri
ti
ca
l
1
2
V
as
cu
Q
o
l
sc
o
re
2
.2
7
<
0
.0
0
0
1
P
ai
n
2
.7
<
0
.0
0
0
1
Fo
rb
e
s
e
t
al
.1
8
2
2
8
/1
1
9
SF
-3
6
3
8
N
R
C
ri
ti
ca
l
1
2
b
E
Q
-5
D
in
d
e
x
0
.3
4
N
R
E
Q
-5
D
P
hy
si
ca
l
fu
n
ct
io
n
1
4
.3
5
N
R
V
as
cu
Q
o
l
P
hy
si
ca
l
ro
le
1
8
.4
N
R
P
ai
n
2
8
.0
7
N
R
V
as
cu
Q
o
L
sc
o
re
1
.7
7
N
R
N
S:
n
o
t
si
gn
ifi
ca
n
t;
N
R
:
n
o
t
re
p
o
rt
e
d
.
O
n
ly
ar
ti
cl
e
s
re
p
o
rt
in
g
tr
e
at
m
e
n
t
sp
e
ci
fic
b
e
fo
re
an
d
af
te
r
d
at
a
ar
e
lis
te
d
.
a
M
e
an
o
r
m
e
d
ia
n
.
b
Tw
e
lw
e
-m
o
n
th
fo
llo
w
-u
p
w
as
se
le
ct
e
d
b
e
ca
u
se
o
f
ve
ry
lit
tl
e
fo
llo
w
-u
p
at
3
6
m
o
n
th
s
(o
ri
gi
n
al
st
u
d
y
e
n
d
p
o
in
t)
.
Donker et al. 93
They all showed increased QoL scores, but a signiﬁcant
diﬀerence between both treatments was not found. This
suggests that the decision for treatment modality
should not be based on QoL, which is similar after
both types of intervention.
Surgical reconstructive intervention will increase
patients’ QoL scores, at least for short-term analyses.
The long-term analysis reported by van Hattum et al.29
showed that the increment in QoL scores may not be
everlasting, and QoL scores may deteriorate at long-
term follow-up.
Very little is known on QoL after major lower limb
amputation. Only two studies were found which
assessed QoL after this type of intervention. Johnson
et al.19 stated that QoL of patients suﬀering from crit-
ical limb ischemia is higher in patients who underwent
successful revascularization compared to patients who
underwent primary or secondary amputations.
Remes et al.33 stated that PAD patients who received
lower extremity amputation have lower QoL scores
compared to healthy control subjects. How PAD
patients’ QoL relates to other chronically illnesses is
unclear. This study only analyzed QoL after amputa-
tion and compared these scores to a healthy control
subject, not evaluating QoL change over time.
There are several problems we encountered while
working on our study. First, in this review we used
the term QoL even for studies that used health status
questionnaires because they presented their results as
QoL scores. For instance, the SF-36 (and the
Rand-36) is a health status questionnaire. A study per-
formed by Breek et al.,8 showed that there is a discrep-
ancy between QoL scores and health status scores.
Patients who scored relatively high on one scale could
easily score lower on the other. Therefore, it is hard to
compare studies with diﬀerent questionnaires in a reli-
able way. Health status questionnaires should generally
not be used for assessing patients’ QoL. Best results can
be achieved by using either a general QoL question-
naire or a disease speciﬁc QoL questionnaire. Also,
the duration of follow-up in the included studies
varied signiﬁcantly, which makes it diﬃcult to compare
the results. Moreover, the number of included patients
in many studies is small, which may lead to type-II
errors. Finally, no studies were randomized and most
were retrospective observational studies. There may be
signiﬁcant publication bias in the included studies, as
positive results are more likely to be reported and
published.
In conclusion, all types of interventions performed in
patients with PAD may improve QoL or QoL-related
aspects. However, the increment is not homogeneous
and depends on the studied population, type of inter-
vention, questionnaire used, scoring method and dur-
ation of follow-up. Little is known about the long-term
follow-up QoL after vascular intervention. Only a small
number of studies analyzed QoL in patients who under-
went lower limb amputation. These studies were not
speciﬁcally designed to analyze the eﬀect of lower
limb amputation on QoL scores before and after sur-
gery. Randomized studies are required to provide evi-
dence of the true beneﬁt of intervention in patients
with PAD.
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